BioCentury
ARTICLE | Clinical News

Repel-CV regulatory update

September 24, 2007 7:00 AM UTC

FDA's Circulatory System Devices Panel of the Medical Devices Advisory Committee recommended approval of Repel-CV to reduce the extent and severity of post-operative adhesions following open-heart sur...